Artiva Biotherapeutics (ARTV) Other financing activities (2024 - 2025)
Artiva Biotherapeutics' (ARTV) quarterly Other financing activities came in at $138000.0 in Q1 2025, up 500.0% on a QoQ basis from $23000.0 in Q4 2024.
Artiva Biotherapeutics (ARTV) Other financing activities (2024 - 2025) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 2 years of Other financing activities data on file, last reported at $138000.0 in Q1 2025.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $138000.0 in Q1 2025; TTM through Dec 2025 was $138000.0, a 375.86% increase from a year earlier, with the FY2025 full-year figure at $138000.0, up 170.59% from the prior year.
- Other financing activities for Q1 2025 stood at $138000.0, up from $23000.0 in the prior quarter.
- Over the last five years, Other financing activities for ARTV reached as high as $138000.0 in Q1 2025 and fell as low as $6000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Artiva Biotherapeutics | 249.99 Mn | 249.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 138,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |